Filing
Spy
Filing
Spy
Home
About
AVXS
Avexis Inc
Gene therapy company developing treatments for rare neurological genetic diseases
CUSIP: 05366U100
Healthcare
US
1 holder
Ownership
Activity
2017 Q4
2 of 5 quarters
Total Value
$52.94M
Total Shares
478.3K
Net Share Change
-113.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$52.94M
478.3K
0.3%
TRIM
-113.0K
(-19.1%)
Viking Global Investors
$52.94M
478.3K shares
TRIM
-113.0K
(-19.1%)
AVXS — Avexis Inc - FilingSpy